Rebecca Zacks
Rebecca is Xconomy's cofounder and executive editor. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University. Before becoming a journalist, she worked in the MIT lab of Nobel prizewinning neuroscientist Susumu Tonegawa.
Recent posts
-
Not much deals news to round up this week, thanks to the Monday holiday and the fact that last week’s roundup slipped to this week. But just in case you missed it…... Read more »
-
It’s been a short week and a long weekend since last I rounded up New England’s life sciences news, but there were still a few stories worth mentioning.
—Luke took an in-depth look at giant Amgen’s... Read more »
-
It was a busy week in the land of New England life sciences. Let’s dive in.
—Luke did a massive analysis of the financial health of all the public biotech companies we follow the... Read more »
-
As has been the case in recent weeks, M&A news featured prominently in this week’s New England tech and life sciences deals.
—Harvard spinoff Tetraphase Pharmaceuticals of Watertown, MA, raised $10 million... Read more »
-
Notice anything new here? Over to the right a little… Little more… Next to the map? (Bear with me, loyal RSS and e-mail subscribers, this will all make sense in a minute.)
Today marks... Read more »
-
The big news this week was obviously the A123Systems IPO, but quite a few other New England tech and life sciences firms had deals to report as well.
—Mansfield, MA-based PrimeraDx—a developer... Read more »
-
New England’s diagnostics developers provided more than their fair share of life sciences news this week.
—Rick Jones, CEO of Cambridge, MA-based Ascent Therapeutics, talked with Ryan about his startup’s... Read more »
-
The Cambridge, MA-based Biogen Idec (NASDAQ: BIIB) today began a $14.50-per-share tender offer for Redwood City, CA-based Facet Biotech (NASDAQ: FACT). Biogen initially proposed to acquire the California company... Read more »
-
New England’s tech and life sciences companies have cut far too many deals to mention over the last week and a half, so we’re kicking it top-ten style for this installment of roundup.... Read more »
-
This week saw the demise of a couple of New England life sciences firms and the rise of several others.
—Luke profiled the efforts of Cambridge, MA-based Acceleron Pharma to bring its lead... Read more »
-
Highland Capital Partners of Boston led a $9 million first round of financing for InXpo, the Chicago-based startup announced. Founded in 2004, InXpo creates virtual events and virtual business environments... Read more »
-
The buyout of Sepracor was probably the biggest piece of New England life sciences news this past week, but it certainly wasn’t the only one.
—Cambridge, MA-based Quanterix named David Okrongly its... Read more »
-
As we’ve grown Xconomy.com over the last few years, we’ve prided ourselves on keeping our operations lean and mean, in no small part by making the most of DIY technologies and... Read more »
-
The pace of New England tech and life sciences deal making was swift over the last week and a half—and there was noticeable bump in M&A transactions.
—Boston-based RockPort Capital Partners participated... Read more »
-
First Wind, the Newton, MA-based developer and operator of wind farms, nabbed $40.4 million in federal financing for a planned installation at Stetson Ridge in Maine, Mass High Tech reports. The... Read more »
-
New England’s life sciences startups gave us a lot to write about last week.
—Luke talked with Genocea Biosciences CEO Staph Bakali about his Cambridge, MA-based startup’s strategy for developing new vaccines. The... Read more »
-
In what I think is a first for the deals roundup, it was all venture all the time for New England’s tech and life sciences companies this past week.
—Greentech Media, the... Read more »
-
Boston- and Cambridge-based tech and life sciences firms cut the usual assortment of deals this week, but their brethren further out in New England were unusually active as well.
—Marathon Technologies ... Read more »
-
This week we had the usual mix of news on partnerships, clinical trials, and the like, as well as some fascinating in-depth discussions with key players in the life sciences arena.
—... Read more »
-
New England tech and life sciences firms forged several interesting new partnerships this week.
—Apperian, a Boston-based startup developing enterprise-oriented iPhone applications, raised $1 million in a Series A venture round led by... Read more »
